The Centers for Disease Control and Prevention (CDC) today confirmed two new variant flu cases in Iowa, according to its weekly Fluview update.
One case involves the influenza A H3N2 variant (H3N2v) and the other the influenza A H1N2 variant (H1N2v). Both infections are in children. Neither was hospitalized, and both have fully recovered, the CDC said.
Screening of a network of urban streams in Baltimore revealed high concentrations of pharmaceuticals, including antibiotics, researchers reported this week in Environmental Science & Technology.
The World Health Organization (WHO) today issued an update to its consolidated guidelines on the detection of tuberculosis (TB) and drug-resistant TB.
The global prevalence of vancomycin-resistant Staphylococcus aureus (VRSA) has more than tripled in the past two decades, according to a systematic review and meta-analysis yesterday in Antimicrobial Resistance & Infection Control.
Implementing daily, pharmacist-driven antifungal stewardship activities at a tertiary care hospital in Turkey was associated with significant improvements in the appropriateness of antifungal therapy, Turkish researchers reported yesterday in Antimicrobial Agents and Chemotherapy.
Germany recently reported a human variant H1N1 (H1N1v) case involving a 17-year-old boy who works on a pig farm, according to a recent weekly communicable disease update from the European Centre for Disease Prevention and Control (ECDC).
A survey of 164 New York physicians found that one in five were severely distressed during their first COVID-19 triage decisions and last-minute training did not appear to alleviate stress, according to a study yesterday in Disaster Medicine and Public Health Preparedness.
Preventive use of bamlanivimab lowered the risk of symptomatic COVID-19 in staff and residents of skilled nursing and assisted living facilities in the United States, according to a study yesterday in JAMA.
The Global Antibiotic Research and Development Partnership (GARDP), on behalf of the Drugs for Neglected Diseases initiative, issued a statement this week that called on World Health Organization (WHO) member states to strengthen their responses to antimicrobial resistance (AMR).
The Democratic Republic of the Congo (DRC) health ministry today declared the end of the country's 12th Ebola outbreak, given that 42 days have passed with no new cases since the last patient was released from treatment.
